Integra LifeSciences Holdings Corporation (NasdaqGS:IART) acquired Tarsus Medical Inc. for $19 million on January 24, 2013. Under the terms of the deal, Integra LifeSciences Holdings acquired all outstanding preferred and common stock of Tarsus Medical, Inc. for $3 million which includes amounts paid into escrow, subject to certain working capital adjustments. The acquisition agreement includes a provision whereby Integra must pay additional cash considerations, the first of $1.5 million and the second up to $14.5 million to the selling shareholders of Tarsus Medical, Inc. These payments are based on reaching certain sales of acquired products. The impact of the Tarsus acquisition is not material to the consolidated operating results of Integra LifeSciences Holdings Corporation.

Integra LifeSciences Holdings Corporation (NasdaqGS:IART) completed the acquisition of Tarsus Medical Inc. on January 24, 2013.